Preliminary Study of a 1,5-Benzodiazepine-Derivative Labelled with Indium-111 for CCK-2 Receptor Targeting.

导出 OA

翻译打印收藏纠错

作者： Marco,Verona ^[1] ; Sara,Rubagotti ^[2] ; Stefania,Croci ^[3] ; Sophia,Sarpaki ^[4] ; Francesca,Borgna ^[1] ; Marianna,Tosato ^[5] ; Elisa,Vettorato ^[1] ; Giovanni,Marzaro ^[1] ; Francesca,Mastrotto ^[6] ; Mattia,Asti ^[1]

作者单位： Department of Pharmaceutical Sciences, University of Padova, via Marzolo 5, 35131 Padova, Italy. ^[1] Radiopharmaceutical Chemistry Section, Nuclear Medicine Unit, AUSL-IRCCS di Reggio Emilia, Viale Risorgimento 80, 42122 Reggio Emilia, Italy. ^[2] Clinical Immunology, Allergy, and Advanced Biotechnologies Unit, Diagnostic Imaging and Laboratory Medicine Department, AUSL-IRCCS di Reggio Emilia, Viale Risorgimento 80, 42122 Reggio Emilia, Italy. ^[3] Bioemtech, Lefkippos Attica Technology Park N.C.S.R. "DEMOKRITOS" Patr. Gregoriou E & 27 Neapoleos Str. Ag. Paraskevi, 15341 Athens, Greece. ^[4] Department of Chemical Sciences, University of Padova, via Marzolo 1, 35131 Padova, Italy. ^[5] Legnaro National Laboratories, Italian Institute of Nuclear Physics, Viale dell'Università 2, 35020 Legnaro (Padova), Italy. ^[6]

关键词 cholecystokinin-2 receptor indium-111 labelling nastorazepide radiopharmaceuticals